⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Danaher's (DHR) Subsidiary Envista Closes IPO, Shares Up

Published 09/22/2019, 11:06 PM
Updated 07/09/2023, 06:31 AM
AMZN
-
RTX
-
DHR
-
FSS
-
GFF
-

Danaher Corporation’s (NYSE:DHR) dental subsidiary, Envista Holdings Corporation, declared that it has successfully closed the initial public offering (IPO) of its common shares, which was announced this June. Envista started trading on the NYSE from Sep 18, 2019.

On Sep 20, shares of Danaher increased 0.49%, closing the trading session at $146.47. Meanwhile, Envista’s share price grew 2.75% to $28.77. Notably, Envista’s shares have gained 2.93% since it started trading on the stock exchange.

Inside the Headlines

As noted, Envista’s offering size amounted to 30,783.2 thousand shares, consisting of 26,768 thousand shares sold to the public at $22.00 per share and 4,015.2 thousand shares bought by the underwriters (exercising fully the option vested on them). The purchase price for the underwriters (after adjusting for underwriting discounts) was less than $22.00 for each share.

Net proceeds (after deduction of commissions and underwriting discounts) were $643.4 million. Envista has awarded the net proceeds to Danaher as part payment for the transfer of its dental assets.

Currently, Danaher holds approximately 80.6% shares in Envista.

About Envista

Envista consists of Danaher Dental segment's three operating businesses — Nobel Biocare Systems, Ormco and KaVo Kerr. These businesses specialize in dental equipment, orthodontics, dental implants and consumables. Some notable brands are Nobel Biocare, Kerr, i-CAT, KaVo, Dexis, Pelton & Crane, Metrex, Ormco, Implant Direct, and Orascoptic.

Envista provides services to dentists (more than one million) across as many as 150 countries. It employs 12,000 people.

Zacks Rank, Earnings Estimates and Price Performance

With a market capitalization of approximately $105.1 billion, Danaher currently carries a Zacks Rank #2 (Buy). Over the past 60 days, the Zacks Consensus Estimate for its 2019 earnings remained stable at $4.79, while increased 2.4% to $5.59 for 2020.

Danaher Corporation Price and Consensus

Danaher Corporation Price and Consensus

Danaher Corporation price-consensus-chart | Danaher Corporation Quote

In the past three months, shares of the company have gained 3.1% against the industry’s 1.7% decline.



Other Stocks to Consider

Three other top-ranked stocks in the same industry are Federal Signal Corporation (NYSE:FSS) , Griffon Corporation ( (NYSE:GFF) ) and United Technologies Corporation (NYSE:UTX) . While Federal Signal and Griffon currently sport a Zacks Rank #1 (Strong Buy), United Technologies carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Over the past 60 days, these companies witnessed an upward revision in the current year's earnings estimate. In the last reported quarter, Federal Signal, Griffon and United Technologies delivered a positive earnings surprise of 19.57%, 10.71% and 7.84%, respectively.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Danaher Corporation (DHR): Free Stock Analysis Report

Federal Signal Corporation (FSS): Free Stock Analysis Report

United Technologies Corporation (UTX): Free Stock Analysis Report

Griffon Corporation (GFF): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.